US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

MAZE holding history

Maze Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MAZE overview All 13F holders of MAZE Full Q2 2026 holdings

Shares (Q2 2026): 80
Value: $2.39K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of MAZE by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	80	$2.39K	<0.1%	+71+788.9%	Added	Holders
Q1 2026	9	$269	<0.1%	−32−78.0%	Reduced	Holders
Q4 2025	41	$1.70K	<0.1%	+41	New	Holders